| 发明名称 |
Use of amylin in pharmaceutical screens. |
| 摘要 |
<p>This invention describes a series of assays useful in evaluating the efficacy of agents which inhibit the neurotoxic effects of beta -amyloid peptide. These assays employ amyloidogenic amylin or beta 2-microglobulin as the target protein instead of the beta -amyloid peptide.</p> |
| 申请公布号 |
EP0646792(A1) |
申请公布日期 |
1995.04.05 |
| 申请号 |
EP19940306053 |
申请日期 |
1994.08.17 |
| 申请人 |
ELI LILLY AND COMPANY;ATHENA NEUROSCIENCES, INC. |
发明人 |
MAY, PATRICK CORNELIOUS;RYDEL, RUSSELL EUGENE |
| 分类号 |
G01N33/15;C07K14/47;C07K14/575;C07K14/74;G01N33/68;(IPC1-7):G01N33/50 |
主分类号 |
G01N33/15 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
